课题基金 / 基金详情

PROGRAM LEADERS

PROGRAM LEADERS
项目负责人
批准号：
8378375
负责人：
SARA A COURTNEIDGE
金额：
$18.44万
依托单位：
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
项目状态：
已结题
起止时间：
2012-05-21 至 2015-04-30
来源：
https://reporter.nih.gov/project-details/8378375
关键词：
ATF2 geneArizonaAwardBiochemistryCancer BiologyCancer Center Support GrantCellular biologyDNA DamageDNA Tumor VirusesDevelopmentDisciplineDoctor of PhilosophyEnzymesFoundationsFundingGrantHypoxiaImmunologyInstitute for Cancer PreventionInstitutesIsraelJournalsLeadershipLeftMAPK14 geneMAPK8 geneMalignant NeoplasmsMelanoma CellMolecular BiologyPharmacologic SubstancePhosphotransferasesPigmentsPositioning AttributePostdoctoral FellowProcollagen-Proline DioxygenaseRecruitment ActivityRegulationResearchRoleScientistSignal PathwaySignal TransductionSignal Transduction PathwaySite VisitStudy SectionThe Wistar InstituteTimeTrainingTumor Suppressor ProteinsUbiquitinUnited States National Institutes of HealthUniversitiesWorkanticancer researchcancer research center directorcareerdrug discoverymedical schoolsmelanomamembermetabolomicspost-doctoral trainingprogramsresponsetranscription factortumortumorigenesisubiquitin ligaseultraviolet irradiation

项目成果

SARA A COURTNEIDGE的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validating and Characterizing a New Melanoma Therapeutic Target
Validating and Characterizing a New Melanoma Therapeutic Target
Src, p53 and estrogen receptor-positive breast cancer
Src, p53 and estrogen receptor-positive breast cancer
海外基金